Achlasia cardia

Reading File
Finding Sources
Searching Images

achalasia cardia barium swallow bird beak esophagus

This diagnostic image consists of two views of a barium swallow x-ray radiography, showing the upper gastrointestinal tract in an anteroposterior and lateral perspective. The esophagus is markedly dilated (megaesophagus) with significant retention of the radiopaque barium contrast medium. At the gastroesophageal junction, there is a smooth, tapered narrowing of the distal esophagus, creating the classic 'bird's beak' appearance characteristic of achalasia. This narrowing represents the failure of the lower esophageal sphincter (LES) to relax. In the stomach, the barium presents a 'snowflake-falling' pattern, indicating irregular distribution and altered gastric filling. These findings are primary indicators of esophageal motility disorders, specifically achalasia, where the primary educational focus is on identifying the combination of proximal dilation and distal muscular obstruction at the cardia. This clinical imaging is essential for students and residents to recognize stages of Achalasia Cardia (AC) based on esophageal diameter and morphology.

This diagnostic image consists of two views of a barium swallow x-ray radiography, showing the upper gastrointestinal tract in an anteroposterior and lateral perspective. The esophagus is markedly dilated (megaesophagus) with significant retention of the radiopaque barium contrast medium. At the gastroesophageal junction, there is a smooth, tapered narrowing of the distal esophagus, creating the classic 'bird's beak' appearance characteristic of achalasia. This narrowing represents the failure of the lower esophageal sphincter (LES) to relax. In the stomach, the barium presents a 'snowflake-falling' pattern, indicating irregular distribution and altered gastric filling. These findings are primary indicators of esophageal motility disorders, specifically achalasia, where the primary educational focus is on identifying the combination of proximal dilation and distal muscular obstruction at the cardia. This clinical imaging is essential for students and residents to recognize stages of Achalasia Cardia (AC) based on esophageal diameter and morphology.

This composite diagnostic image illustrates the clinical findings of achalasia through multiple modalities. (A) Barium swallow (upper GI angiography) displays a significantly dilated esophageal lumen with a classic 'bird’s beak' sign, characterized by smooth, symmetric tapering at the gastroesophageal junction. (B, C) Endoscopic views (EGD) demonstrate stagnant food residue and extensive white mucosal plaques in the mid-esophagus, suggestive of secondary candidiasis or stasis-induced changes. View C specifically shows a tightly closed cardia that provided resistance to the endoscope. (D) A high-resolution esophageal manometry (HRM) topographic plot reveals aperistalsis in the esophageal body (low-pressure/green zones) and impaired relaxation of the lower esophageal sphincter (LES), indicated by persistent high-pressure bands at the distal end. Together, these images teach the classic triad of achalasia: esophageal dilation, failure of LES relaxation, and loss of peristalsis, useful for gastroenterology and radiology trainees.

This composite diagnostic image illustrates the clinical findings of achalasia through multiple modalities. (A) Barium swallow (upper GI angiography) displays a significantly dilated esophageal lumen with a classic 'bird’s beak' sign, characterized by smooth, symmetric tapering at the gastroesophageal junction. (B, C) Endoscopic views (EGD) demonstrate stagnant food residue and extensive white mucosal plaques in the mid-esophagus, suggestive of secondary candidiasis or stasis-induced changes. View C specifically shows a tightly closed cardia that provided resistance to the endoscope. (D) A high-resolution esophageal manometry (HRM) topographic plot reveals aperistalsis in the esophageal body (low-pressure/green zones) and impaired relaxation of the lower esophageal sphincter (LES), indicated by persistent high-pressure bands at the distal end. Together, these images teach the classic triad of achalasia: esophageal dilation, failure of LES relaxation, and loss of peristalsis, useful for gastroenterology and radiology trainees.

This diagnostic image is a contrast esophagogram (barium swallow) of the upper gastrointestinal tract. The radiograph reveals a significantly dilated esophagus filled with radiopaque barium contrast. There is a classic 'bird's beak' appearance at the distal esophagus, characterized by a smooth, symmetric, and tapered narrowing as the lumen approaches the gastroesophageal junction. This radiographic finding is pathognomonic for achalasia, reflecting the failure of the lower esophageal sphincter (LES) to relax and the loss of esophageal peristalsis. The contrast outlines a clear transition from the proximal megaesophagus to the functional obstruction at the cardia. This image is a primary educational tool for illustrating the diagnostic features of esophageal motility disorders in gastroenterology and radiology. It demonstrates the clinical significance of barium studies in evaluating patients presenting with symptoms such as dysphagia, regurgitation, and weight loss.

This diagnostic image is a contrast esophagogram (barium swallow) of the upper gastrointestinal tract. The radiograph reveals a significantly dilated esophagus filled with radiopaque barium contrast. There is a classic 'bird's beak' appearance at the distal esophagus, characterized by a smooth, symmetric, and tapered narrowing as the lumen approaches the gastroesophageal junction. This radiographic finding is pathognomonic for achalasia, reflecting the failure of the lower esophageal sphincter (LES) to relax and the loss of esophageal peristalsis. The contrast outlines a clear transition from the proximal megaesophagus to the functional obstruction at the cardia. This image is a primary educational tool for illustrating the diagnostic features of esophageal motility disorders in gastroenterology and radiology. It demonstrates the clinical significance of barium studies in evaluating patients presenting with symptoms such as dysphagia, regurgitation, and weight loss.

A three-panel figure documenting the diagnosis and management of achalasia of the cardia using a self-expandable metal stent (SEMS). Panel A: A preoperative upper gastrointestinal barium swallow radiograph (X-ray) showing classic features of achalasia. There is marked proximal esophageal dilation with a smooth, tapered narrowing at the gastroesophageal junction, creating a pathognomonic 'bird-beak' or 'beak-like' appearance, resulting in barium retention. Panel B: An endoscopic view showing a fully expanded, mesh-like metallic stent positioned within the esophageal lumen. The stent's lattice structure is in close apposition to the pink, slightly inflamed esophageal mucosa, ensuring patency. Panel C: Postoperative barium swallow radiograph showing the esophagus following stent placement. The contrast medium now passes freely through the previously constricted cardia into the stomach, indicating successful relief of the obstruction. This series illustrates the clinical transition from mechanical obstruction to restored luminal patency in a pediatric patient with refractory esophageal stricture.

A three-panel figure documenting the diagnosis and management of achalasia of the cardia using a self-expandable metal stent (SEMS). Panel A: A preoperative upper gastrointestinal barium swallow radiograph (X-ray) showing classic features of achalasia. There is marked proximal esophageal dilation with a smooth, tapered narrowing at the gastroesophageal junction, creating a pathognomonic 'bird-beak' or 'beak-like' appearance, resulting in barium retention. Panel B: An endoscopic view showing a fully expanded, mesh-like metallic stent positioned within the esophageal lumen. The stent's lattice structure is in close apposition to the pink, slightly inflamed esophageal mucosa, ensuring patency. Panel C: Postoperative barium swallow radiograph showing the esophagus following stent placement. The contrast medium now passes freely through the previously constricted cardia into the stomach, indicating successful relief of the obstruction. This series illustrates the clinical transition from mechanical obstruction to restored luminal patency in a pediatric patient with refractory esophageal stricture.

Searching PubMed

achalasia cardia treatment

Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
I now have enough comprehensive information to write a detailed, structured answer on achalasia cardia.

Achalasia Cardia

Definition

Achalasia cardia (esophageal achalasia) is a primary esophageal motor disorder characterized by two cardinal features:
  1. Impaired or absent relaxation of the lower esophageal sphincter (LES) with swallowing
  2. Aperistalsis of the smooth muscle esophagus
It is the best-characterized of the esophageal motility disorders. - Sleisenger & Fordtran's GI and Liver Disease

Epidemiology

  • Incidence: ~1 per 100,000 population per year
  • Prevalence: ~10 per 100,000
  • Affects males and females equally
  • Bimodal age distribution: peaks in 20-40 years and again after 60 years

Pathophysiology

Core Defect

The primary problem is loss of ganglion cells in the myenteric (Auerbach) plexus of the smooth muscle esophagus, including the LES. The degree of ganglion cell loss parallels the duration of disease.

Inhibitory Neuron Loss

The inhibitory ganglion neurons (which release nitric oxide (NO) and vasoactive intestinal peptide/VIP) are the earliest and most critically affected. These neurons mediate:
  • Deglutitive inhibition (LES relaxation)
  • Sequenced propagation of esophageal peristalsis
Their absence explains both key physiologic abnormalities - impaired LES relaxation AND aperistalsis.
Achalasia tissue shows absent NO synthase and a marked reduction of VIP-staining neurons at the gastroesophageal junction.

Excitatory Neuron Involvement

Partial impairment of postganglionic cholinergic pathways also occurs - muscle strips contract to direct ACh but fail to respond to ganglionic (nicotinic) stimulation.
CCK (which normally stimulates inhibitory neurons and reduces LES pressure) paradoxically increases LES pressure in achalasia - a hallmark of the inhibitory defect.

Etiology of Ganglion Cell Loss

Evidence points to an autoimmune process in genetically susceptible individuals:
  • Myenteric plexus infiltrate shows cytotoxic T cells (resting and activated)
  • Antibodies against myenteric neurons detected in patient sera (especially with specific HLA alleles)
  • Suspected trigger: chronic latent HSV-1 infection (HSV-1 also found in LES of non-achalasic organ donors, suggesting genetic predisposition is required)

Chicago Classification (High-Resolution Manometry Subtypes)

TypeHRM FindingFeatures
Type I (Classic)Aperistalsis, no pressurizationAdvanced disease; dilated esophagus
Type IIAperistalsis + panesophageal pressurizationIntermediate disease
Type III (Spastic)Premature/spastic distal contractionsUnique pathogenesis - plexus inflammation without destruction; no LES relaxation
Types I and II represent a continuum (II progressing to I). Type III has a distinct pathogenesis.

Clinical Features

Cardinal Symptoms:
  • Dysphagia - present in ALL patients for solids; majority also have liquid dysphagia. Gradual onset, often present for years before diagnosis. Eventually plateaus.
  • Regurgitation - nonbilious, non-acid, mixed with saliva. Classic: food eaten hours or days earlier is regurgitated. Worsens with recumbency.
  • Chest pain - in ~2/3 of patients early in disease course. Related to esophageal spasm (possibly longitudinal muscle). May spontaneously improve over time.
Other Features:
  • Weight loss
  • Hiccups
  • Halitosis (from fermentation of retained food)
  • Paradoxical "heartburn" - actually due to bacterial fermentation of retained food causing esophageal acidification, NOT true GER
  • Aspiration pneumonia (up to 10% with advanced disease)
  • Rarely: airway compromise/stridor from a dilated esophagus compressing the membranous trachea

Diagnosis

1. Barium Swallow

Classic finding: "Bird's beak" appearance - dilated esophagus tapering smoothly to a narrow segment at the gastroesophageal junction, with failure of barium to pass freely into the stomach.
Barium swallow showing classic bird's beak appearance of achalasia
Multi-modality achalasia findings: barium swallow, endoscopy, and HRM

2. High-Resolution Manometry (HRM) - Gold Standard

  • Absent or markedly impaired LES relaxation (elevated integrated relaxation pressure, IRP)
  • Aperistalsis in the esophageal body
  • Allows subtype classification (Types I, II, III)

3. Endoscopy

  • Required in all patients to exclude pseudoachalasia (malignancy at the cardia)
  • May show: dilated esophagus, retained food/saliva, "pop" when endoscope passes through the tight cardia
  • Endoscopic view shows tightly closed cardia with resistance to scope passage

4. Other

  • CT scan/EUS: to rule out infiltrative/extrinsic causes
  • Timed barium esophagram: useful for monitoring treatment response

Differential Diagnosis

  • Pseudoachalasia - malignancy (gastric, lung, pancreatic), infiltrative disease, or post-surgical distortion mimicking achalasia. Distinguished by shorter symptom duration, age >50, marked weight loss, CT/EUS findings.
  • Chagas disease - T. cruzi infection destroying myenteric ganglion cells. Produces identical picture but with additional visceral involvement (megacolon, megaduodenum, cardiomyopathy). Diagnosed by serology/PCR.
  • Distal esophageal spasm (DES) - differs in that LES relaxation is preserved (except in spastic achalasia/Type III)
  • Other: scleroderma, EoE, GERD with stricture

Treatment

The underlying neuropathology cannot be corrected - treatment aims to reduce LES pressure to improve esophageal emptying by gravity.

1. Pharmacologic (Temporizing Only)

  • Nitrates (sublingual isosorbide dinitrate) and calcium channel blockers (nifedipine 30-40 mg/day before meals) - reduce LES pressure; limited efficacy, significant side effects (headache, flushing, orthostasis)
  • Sildenafil (50 mg) - blocks PDE-5, increases cGMP from NO; peaks at 15-20 min, lasts <1 hour. Limited by cost and side effects.
  • Best reserved as temporizing measures; not definitive treatment.

2. Botulinum Toxin Injection (Endoscopic)

  • 80-100 units injected into the LES in 4 quadrants (intrasphincteric)
  • Mechanism: irreversibly inhibits ACh release from cholinergic terminals, reducing neurogenic LES pressure
  • ~66% improvement in dysphagia at 6 months; minimal efficacy at 1 year
  • Repeat injections possible but cause fibrosis, limiting long-term use
  • Best reserved for elderly/frail patients who are poor surgical candidates

3. Pneumatic Dilation

  • Requires distension of LES to ≥3 cm to partially disrupt circular sphincter muscle
  • Uses Rigiflex balloons (3.0, 3.5, 4.0 cm) over a guidewire, positioned fluoroscopically
  • Outpatient procedure under conscious sedation
  • Efficacy: ~85-90% overall; type II achalasia responds best (up to 100% in the European RCT)
  • Main risk: esophageal perforation (~1%)
  • May require repeat dilations

4. Surgical Heller Myotomy (Laparoscopic)

  • Longitudinal division of the LES circular muscle (cardiomyotomy)
  • Usually combined with partial fundoplication (Dor or Toupet) to prevent post-op GERD
  • Efficacy: ~90%; effective across all subtypes
  • Type III achalasia responds better to myotomy (86%) than to pneumatic dilation (40%)
  • Risk of perforation: ~1% (comparable to pneumatic dilation)

5. POEM (Per-Oral Endoscopic Myotomy)

  • Endoscopic approach creating a submucosal tunnel to perform myotomy
  • Particularly effective for Type III (spastic) achalasia due to ability to extend the myotomy proximally
  • Efficacy comparable to Heller myotomy; avoids external incisions
  • Post-POEM GERD is a concern (no anti-reflux procedure done)
  • Recent meta-analysis (PMID 40399616) comparing POEM vs Heller myotomy outcomes confirms comparable efficacy

Treatment Choice by Subtype:

SubtypePreferred Treatment
Type IHeller myotomy or POEM
Type IIPneumatic dilation (first-line) or Heller/POEM
Type IIIPOEM or Heller myotomy (dilation less effective)

Complications

ComplicationNotes
Aspiration pneumoniaFrom nocturnal regurgitation
Esophageal candidiasisFrom stasis of food/secretions
Esophageal carcinomaLong-term risk; ~16x increased risk of squamous cell carcinoma
MegaesophagusEnd-stage progressive dilation
Airway compromiseDilated esophagus compressing trachea (rare)
Post-treatment GERDEspecially after myotomy without fundoplication

Key Points Summary

  • Achalasia = failure of LES relaxation + aperistalsis, due to loss of inhibitory myenteric neurons (NO/VIP)
  • Gold standard diagnosis: high-resolution manometry
  • Classic radiology: "bird's beak" on barium swallow
  • HRM subtypes (I, II, III) guide therapy choice
  • Definitive treatment: pneumatic dilation or Heller myotomy/POEM (~90% efficacy)
  • Botulinum toxin: for poor surgical candidates only
  • All patients need endoscopy to exclude pseudoachalasia/malignancy
Sources: Sleisenger & Fordtran's Gastrointestinal and Liver Disease, pp. 729-738; Clinical Gastrointestinal Endoscopy, 3e; Current Surgical Therapy, 14e
This is a shared conversation. Sign in to Orris to start your own chat.